ARCA biopharma Ownership 2024 | Who Owns ARCA biopharma Now?
Institutional Ownership
106.02%
Insider Ownership
1.29%
Retail Ownership
-7.31%
Institutional Holders
25.00
ARCA biopharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 106.94% | 1.41% | 15,507,760 | 15,507,760 | 100.00% | 59,394,720 | Jun 30, 2024 |
| CABLE CAR CAPITAL LLC | 27.59% | 16.14% | 4,000,452 | - | - | 15,321,731 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 26.52% | 0.14% | 3,846,150 | 3,846,150 | 100.00% | 14,730,755 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 9.65% | 0.08% | 1,400,000 | 1,400,000 | 100.00% | 5,362,000 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 9.54% | 0.00% | 1,382,736 | 1,382,736 | 100.00% | 5,233,656 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 8.28% | 0.01% | 1,200,000 | 1,200,000 | 100.00% | 4,596,000 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 6.90% | 0.16% | 1,000,000 | 1,000,000 | 100.00% | 3,830,000 | Jun 30, 2024 |
| VR ADVISER, LLC | 5.97% | 0.21% | 866,375 | 866,375 | 100.00% | 3,318,216 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 4.83% | 0.07% | 700,000 | 700,000 | 100.00% | 2,681,000 | Jun 30, 2024 |
| MORGAN STANLEY | 4.48% | 0.00% | 650,000 | 650,000 | 100.00% | 2,489,500 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.13% | - | 453,598 | - | - | 1,737,280 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 2.86% | 0.11% | 414,325 | 414,325 | 100.00% | 1,586,865 | Jun 30, 2024 |
| BLACKROCK INC. | 1.71% | - | 247,909 | 16,671 | 7.21% | 949,492 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.12% | 0.00% | 161,735 | 19,386 | 13.62% | 619,527 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.58% | 0.06% | 84,676 | 84,676 | 100.00% | 324,309 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.50% | 0.00% | 73,099 | 7,400 | 11.26% | 279,969 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.50% | 0.03% | 72,484 | 72,484 | 100.00% | 277,614 | Jun 30, 2024 |
| STATE STREET CORP | 0.41% | - | 59,707 | - | - | 228,678,000 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.29% | - | 42,502 | - | - | 162,783 | Jun 30, 2024 |
| ABRDN PLC | 0.22% | 0.00% | 32,461 | - | - | 124,326 | Jun 30, 2024 |
ARCA biopharma's largest institutional shareholder is PERCEPTIVE ADVISORS LLC, holding 106.94% of the company's total share outstanding, currently valued at $59.39M. The top 10 institutional shareholders own together 210.70% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CABLE CAR CAPITAL LLC | 27.59% | 16.14% | 4,000,452 | - | - | 15,321,731 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 106.94% | 1.41% | 15,507,760 | 15,507,760 | 100.00% | 59,394,720 | Jun 30, 2024 |
| VR ADVISER, LLC | 5.97% | 0.21% | 866,375 | 866,375 | 100.00% | 3,318,216 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 6.90% | 0.16% | 1,000,000 | 1,000,000 | 100.00% | 3,830,000 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 26.52% | 0.14% | 3,846,150 | 3,846,150 | 100.00% | 14,730,755 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 2.86% | 0.11% | 414,325 | 414,325 | 100.00% | 1,586,865 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 9.65% | 0.08% | 1,400,000 | 1,400,000 | 100.00% | 5,362,000 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 4.83% | 0.07% | 700,000 | 700,000 | 100.00% | 2,681,000 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.58% | 0.06% | 84,676 | 84,676 | 100.00% | 324,309 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.50% | 0.03% | 72,484 | 72,484 | 100.00% | 277,614 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 8.28% | 0.01% | 1,200,000 | 1,200,000 | 100.00% | 4,596,000 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 9.54% | 0.00% | 1,382,736 | 1,382,736 | 100.00% | 5,233,656 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | 0.01% | 0.00% | 2,000 | 2,000 | 100.00% | 7,660 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.19% | 0.00% | 27,779 | 27,779 | 100.00% | 106,394 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.50% | 0.00% | 73,099 | 7,400 | 11.26% | 279,969 | Jun 30, 2024 |
| ABRDN PLC | 0.22% | 0.00% | 32,461 | - | - | 124,326 | Jun 30, 2024 |
| MORGAN STANLEY | 4.48% | 0.00% | 650,000 | 650,000 | 100.00% | 2,489,500 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.05% | 0.00% | 7,131 | 7,131 | 100.00% | 27,312,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.12% | 0.00% | 161,735 | 19,386 | 13.62% | 619,527 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.29% | - | 42,502 | - | - | 162,783 | Jun 30, 2024 |
The largest ARCA biopharma shareholder by % of total assets is CABLE CAR CAPITAL LLC. The company owns 4.00M shares of ARCA biopharma (ABIO), representing 16.14% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 106.94% | 1.41% | 15,507,760 | 15,507,760 | 100.00% | 59,394,720 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 26.52% | 0.14% | 3,846,150 | 3,846,150 | 100.00% | 14,730,755 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 9.65% | 0.08% | 1,400,000 | 1,400,000 | 100.00% | 5,362,000 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 9.54% | 0.00% | 1,382,736 | 1,382,736 | 100.00% | 5,233,656 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 8.28% | 0.01% | 1,200,000 | 1,200,000 | 100.00% | 4,596,000 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 6.90% | 0.16% | 1,000,000 | 1,000,000 | 100.00% | 3,830,000 | Jun 30, 2024 |
| VR ADVISER, LLC | 5.97% | 0.21% | 866,375 | 866,375 | 100.00% | 3,318,216 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 4.83% | 0.07% | 700,000 | 700,000 | 100.00% | 2,681,000 | Jun 30, 2024 |
| MORGAN STANLEY | 4.48% | 0.00% | 650,000 | 650,000 | 100.00% | 2,489,500 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 2.86% | 0.11% | 414,325 | 414,325 | 100.00% | 1,586,865 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.58% | 0.06% | 84,676 | 84,676 | 100.00% | 324,309 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.50% | 0.03% | 72,484 | 72,484 | 100.00% | 277,614 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.19% | 0.00% | 27,779 | 27,779 | 100.00% | 106,394 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.12% | 0.00% | 161,735 | 19,386 | 13.62% | 619,527 | Jun 30, 2024 |
| BLACKROCK INC. | 1.71% | - | 247,909 | 16,671 | 7.21% | 949,492 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.50% | 0.00% | 73,099 | 7,400 | 11.26% | 279,969 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.05% | 0.00% | 7,131 | 7,131 | 100.00% | 27,312,000 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | 0.01% | 0.00% | 2,000 | 2,000 | 100.00% | 7,660 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.00% | - | 275 | 275 | 100.00% | 1,000 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 50 | - | - | 192 | Jun 30, 2024 |
As of Jun 30 2024, ARCA biopharma's largest institutional buyer is PERCEPTIVE ADVISORS LLC. The company purchased 15.51M stocks of ABIO, valued at $59.39M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WESTERN STANDARD LLC | - | - | - | -1,410,143 | -100.00% | - | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | - | - | - | -706,930 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -12,714 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.00% | - | 344 | -2,731 | -88.81% | 1,318 | Jun 30, 2024 |
| FMR LLC | - | - | - | -201 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -80 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 151 | -25 | -14.20% | 579 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 16 | -2 | -11.11% | 61 | Jun 30, 2024 |
| CABLE CAR CAPITAL LLC | 27.59% | 16.14% | 4,000,452 | - | - | 15,321,731 | Jun 30, 2024 |
| ABRDN PLC | 0.22% | 0.00% | 32,461 | - | - | 124,326 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.29% | - | 42,502 | - | - | 162,783 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.13% | - | 453,598 | - | - | 1,737,280 | Jun 30, 2024 |
| PARALLEL ADVISORS, LLC | 0.00% | - | 244 | - | - | 935 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.14% | - | 20,982 | - | - | 80,361,000 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.10% | - | 14,988 | - | - | 57,404 | Jun 30, 2024 |
| STATE STREET CORP | 0.41% | - | 59,707 | - | - | 228,678,000 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 50 | - | - | 192 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.00% | - | 275 | 275 | 100.00% | 1,000 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | 0.01% | 0.00% | 2,000 | 2,000 | 100.00% | 7,660 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.05% | 0.00% | 7,131 | 7,131 | 100.00% | 27,312,000 | Jun 30, 2024 |
As of Jun 30 2024, ARCA biopharma's biggest institutional seller is WESTERN STANDARD LLC. The company sold -1.41M shares of ABIO, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 106.94% | 1.41% | 15,507,760 | 15,507,760 | 100.00% | 59,394,720 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 26.52% | 0.14% | 3,846,150 | 3,846,150 | 100.00% | 14,730,755 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 9.65% | 0.08% | 1,400,000 | 1,400,000 | 100.00% | 5,362,000 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 9.54% | 0.00% | 1,382,736 | 1,382,736 | 100.00% | 5,233,656 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 8.28% | 0.01% | 1,200,000 | 1,200,000 | 100.00% | 4,596,000 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 6.90% | 0.16% | 1,000,000 | 1,000,000 | 100.00% | 3,830,000 | Jun 30, 2024 |
| VR ADVISER, LLC | 5.97% | 0.21% | 866,375 | 866,375 | 100.00% | 3,318,216 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 4.83% | 0.07% | 700,000 | 700,000 | 100.00% | 2,681,000 | Jun 30, 2024 |
| MORGAN STANLEY | 4.48% | 0.00% | 650,000 | 650,000 | 100.00% | 2,489,500 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 2.86% | 0.11% | 414,325 | 414,325 | 100.00% | 1,586,865 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.58% | 0.06% | 84,676 | 84,676 | 100.00% | 324,309 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.50% | 0.03% | 72,484 | 72,484 | 100.00% | 277,614 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.19% | 0.00% | 27,779 | 27,779 | 100.00% | 106,394 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.05% | 0.00% | 7,131 | 7,131 | 100.00% | 27,312,000 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | 0.01% | 0.00% | 2,000 | 2,000 | 100.00% | 7,660 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.00% | - | 275 | 275 | 100.00% | 1,000 | Jun 30, 2024 |
ARCA biopharma's largest new institutional shareholder by number of shares is PERCEPTIVE ADVISORS LLC, purchased 15.51M shares, valued at $59.39M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WESTERN STANDARD LLC | - | - | - | -1,410,143 | -100.00% | - | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | - | - | - | -706,930 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -12,714 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -201 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -80 | -100.00% | - | Jun 30, 2024 |
ARCA biopharma's largest sold out institutional shareholder by shares sold is WESTERN STANDARD LLC, sold -1.41M shares, valued at -, as of undefined.
ARCA biopharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| TEKLA LIFE SCIENCES INVESTORS | 0.07% | 32,461 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.02% | 46,948 | - | - | Mar 28, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 453,598 | -141,432 | -23.77% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 134,831 | -309 | -0.23% | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 14,988 | - | - | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 20,800 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 32,400 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 5,178 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 1,563 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 2,685 | - | - | Mar 31, 2024 |
ARCA biopharma's largest mutual fund holder by % of total assets is "TEKLA LIFE SCIENCES INVESTORS", owning 32.46K shares, compromising 0.07% of its total assets.
ARCA biopharma Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 25 | 13.64% |
| 31 Mar, 24 | 22 | -15.38% |
| 31 Dec, 23 | 26 | 13.04% |
| 30 Sep, 23 | 23 | -8.00% |
| 30 Jun, 23 | 25 | -13.79% |
| 31 Mar, 23 | 29 | 16.00% |
| 31 Dec, 22 | 25 | -3.85% |
| 30 Sep, 22 | 26 | 4.00% |
| 30 Jun, 22 | 25 | 8.70% |
| 31 Mar, 22 | 23 | 15.00% |
| 31 Dec, 21 | 20 | 17.65% |
| 30 Sep, 21 | 17 | 21.43% |
| 30 Jun, 21 | 14 | -22.22% |
| 31 Mar, 21 | 18 | 12.50% |
| 31 Dec, 20 | 16 | 100.00% |
| 30 Sep, 20 | 8 | 166.67% |
| 30 Jun, 20 | 3 | -40.00% |
| 31 Mar, 20 | 5 | -37.50% |
| 31 Dec, 19 | 8 | 14.29% |
| 30 Sep, 19 | 7 | -12.50% |
| 30 Jun, 19 | 8 | - |
As of 30 Jun 24, 25 institutions are holding ARCA biopharma's shares, representing an increase of 13.64% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 15,374,075 | 113.56% |
| 31 Mar, 24 | 7,198,831 | -3.72% |
| 31 Dec, 23 | 7,477,164 | 129.52% |
| 30 Sep, 23 | 3,257,695 | 15.09% |
| 30 Jun, 23 | 2,830,616 | 12.19% |
| 31 Mar, 23 | 2,523,031 | -3.49% |
| 31 Dec, 22 | 2,614,171 | 17.59% |
| 30 Sep, 22 | 2,223,139 | 32.67% |
| 30 Jun, 22 | 1,675,731 | 47.89% |
| 31 Mar, 22 | 1,133,069 | 1.11% |
| 31 Dec, 21 | 1,120,678 | -26.67% |
| 30 Sep, 21 | 1,528,356 | 28.10% |
| 30 Jun, 21 | 1,193,080 | 36.11% |
| 31 Mar, 21 | 876,576 | 6.76% |
| 31 Dec, 20 | 821,039 | 104.51% |
| 30 Sep, 20 | 401,464 | 195.95% |
| 30 Jun, 20 | 135,652 | -32.46% |
| 31 Mar, 20 | 200,838 | -4.96% |
| 31 Dec, 19 | 211,310 | 24.11% |
| 30 Sep, 19 | 170,259 | -37.53% |
| 30 Jun, 19 | 272,542 | - |
ARCA biopharma (ABIO) has 15.37M shares outstanding as of 30 Jun 24, up 113.56% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 106.02% | 4.25% |
| 31 Mar, 24 | 49.94% | 1.86% |
| 31 Dec, 23 | 51.87% | 10151851.77% |
| 30 Sep, 23 | 0.02% | 0.01% |
| 30 Jun, 23 | 19.64% | 6.41% |
| 31 Mar, 23 | 17.51% | 5.32% |
| 31 Dec, 22 | 18.14% | 7.62% |
| 30 Sep, 22 | 15.43% | 11.41% |
| 30 Jun, 22 | 11.63% | 18.81% |
| 31 Mar, 22 | 7.86% | 12.10% |
| 31 Dec, 21 | 8.06% | 7.17% |
| 30 Sep, 21 | 10.61% | 15.47% |
| 30 Jun, 21 | 8.28% | 16.45% |
| 31 Mar, 21 | 7.09% | 16.07% |
| 31 Dec, 20 | 6.64% | 62.95% |
| 30 Sep, 20 | 3.25% | 269.58% |
| 30 Jun, 20 | 1.10% | 41.56% |
| 31 Mar, 20 | 1.63% | 55.58% |
| 31 Dec, 19 | 1.71% | 90.08% |
| 30 Sep, 19 | 1.38% | 28.32% |
| 30 Jun, 19 | 2.21% | - |
As of 30 Jun 24, ARCA biopharma is held by 106.02% institutional shareholders, representing a 4.25% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 13 | 85.71% |
| 31 Mar, 24 | 7 | -36.36% |
| 31 Dec, 23 | 11 | 57.14% |
| 30 Sep, 23 | 7 | 40.00% |
| 30 Jun, 23 | 5 | -66.67% |
| 31 Mar, 23 | 15 | 36.36% |
| 31 Dec, 22 | 11 | 57.14% |
| 30 Sep, 22 | 7 | -41.67% |
| 30 Jun, 22 | 12 | 20.00% |
| 31 Mar, 22 | 10 | 42.86% |
| 31 Dec, 21 | 7 | -36.36% |
| 30 Sep, 21 | 11 | 22.22% |
| 30 Jun, 21 | 9 | -10.00% |
| 31 Mar, 21 | 10 | -23.08% |
| 31 Dec, 20 | 13 | 116.67% |
| 30 Sep, 20 | 6 | - |
| 30 Jun, 20 | - | -100.00% |
| 31 Mar, 20 | 2 | -60.00% |
| 31 Dec, 19 | 5 | 66.67% |
| 30 Sep, 19 | 3 | -62.50% |
| 30 Jun, 19 | 8 | - |
13 institutional shareholders have increased their position in ABIO stock as of 30 Jun 24 compared to 7 in the previous quarter (a 85.71% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 3 | -25.00% |
| 31 Mar, 24 | 4 | - |
| 31 Dec, 23 | 4 | -50.00% |
| 30 Sep, 23 | 8 | 14.29% |
| 30 Jun, 23 | 7 | 133.33% |
| 31 Mar, 23 | 3 | -25.00% |
| 31 Dec, 22 | 4 | -42.86% |
| 30 Sep, 22 | 7 | 133.33% |
| 30 Jun, 22 | 3 | -25.00% |
| 31 Mar, 22 | 4 | - |
| 31 Dec, 21 | 4 | 100.00% |
| 30 Sep, 21 | 2 | 100.00% |
| 30 Jun, 21 | 1 | -50.00% |
| 31 Mar, 21 | 2 | - |
| 31 Dec, 20 | - | -100.00% |
| 30 Sep, 20 | 1 | -66.67% |
| 30 Jun, 20 | 3 | 50.00% |
| 31 Mar, 20 | 2 | - |
| 31 Dec, 19 | - | -100.00% |
| 30 Sep, 19 | 1 | - |
| 30 Jun, 19 | - | - |
3 institutional shareholders have reduced their position in ABIO stock as of 30 Jun 24 compared to 4 in the previous quarter (a -25.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 25 | 13.64% | 15,374,075 | 113.56% | 106.02% | 4.25% | 13 | 85.71% | 3 | -25.00% |
| 31 Mar, 24 | 22 | -15.38% | 7,198,831 | -3.72% | 49.94% | 1.86% | 7 | -36.36% | 4 | - |
| 31 Dec, 23 | 26 | 13.04% | 7,477,164 | 129.52% | 51.87% | 10151851.77% | 11 | 57.14% | 4 | -50.00% |
| 30 Sep, 23 | 23 | -8.00% | 3,257,695 | 15.09% | 0.02% | 0.01% | 7 | 40.00% | 8 | 14.29% |
| 30 Jun, 23 | 25 | -13.79% | 2,830,616 | 12.19% | 19.64% | 6.41% | 5 | -66.67% | 7 | 133.33% |
| 31 Mar, 23 | 29 | 16.00% | 2,523,031 | -3.49% | 17.51% | 5.32% | 15 | 36.36% | 3 | -25.00% |
| 31 Dec, 22 | 25 | -3.85% | 2,614,171 | 17.59% | 18.14% | 7.62% | 11 | 57.14% | 4 | -42.86% |
| 30 Sep, 22 | 26 | 4.00% | 2,223,139 | 32.67% | 15.43% | 11.41% | 7 | -41.67% | 7 | 133.33% |
| 30 Jun, 22 | 25 | 8.70% | 1,675,731 | 47.89% | 11.63% | 18.81% | 12 | 20.00% | 3 | -25.00% |
| 31 Mar, 22 | 23 | 15.00% | 1,133,069 | 1.11% | 7.86% | 12.10% | 10 | 42.86% | 4 | - |
| 31 Dec, 21 | 20 | 17.65% | 1,120,678 | -26.67% | 8.06% | 7.17% | 7 | -36.36% | 4 | 100.00% |
| 30 Sep, 21 | 17 | 21.43% | 1,528,356 | 28.10% | 10.61% | 15.47% | 11 | 22.22% | 2 | 100.00% |
| 30 Jun, 21 | 14 | -22.22% | 1,193,080 | 36.11% | 8.28% | 16.45% | 9 | -10.00% | 1 | -50.00% |
| 31 Mar, 21 | 18 | 12.50% | 876,576 | 6.76% | 7.09% | 16.07% | 10 | -23.08% | 2 | - |
| 31 Dec, 20 | 16 | 100.00% | 821,039 | 104.51% | 6.64% | 62.95% | 13 | 116.67% | - | -100.00% |
| 30 Sep, 20 | 8 | 166.67% | 401,464 | 195.95% | 3.25% | 269.58% | 6 | - | 1 | -66.67% |
| 30 Jun, 20 | 3 | -40.00% | 135,652 | -32.46% | 1.10% | 41.56% | - | -100.00% | 3 | 50.00% |
| 31 Mar, 20 | 5 | -37.50% | 200,838 | -4.96% | 1.63% | 55.58% | 2 | -60.00% | 2 | - |
| 31 Dec, 19 | 8 | 14.29% | 211,310 | 24.11% | 1.71% | 90.08% | 5 | 66.67% | - | -100.00% |
| 30 Sep, 19 | 7 | -12.50% | 170,259 | -37.53% | 1.38% | 28.32% | 3 | -62.50% | 1 | - |
| 30 Jun, 19 | 8 | - | 272,542 | - | 2.21% | - | 8 | - | - | - |
ARCA biopharma Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
All Insider Owners Trades
The last insider buy of ABIO was made by JANUS HENDERSON GROUP PLC on Jul 26 2024, buying 30,227 shares at $3.05 per share (worth $92.29K).
ARCA biopharma Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 13 | - | - |
| Q1 2024 | 7 | - | - |
| Q4 2022 | 10 | 2 | 500.00% |
| Q3 2022 | 1 | - | - |
| Q2 2022 | 14 | 4 | 350.00% |
| Q4 2021 | 5 | - | - |
| Q2 2021 | 2 | 1 | 200.00% |
| Q1 2021 | 5 | - | - |
| Q4 2020 | 5 | - | - |
| Q3 2020 | 3 | - | - |
| Q2 2018 | - | 2 | - |
| Q1 2018 | 5 | 15 | 33.33% |
| Q3 2017 | 1 | - | - |
| Q2 2017 | 1 | 5 | 20.00% |
| Q1 2017 | 15 | 5 | 300.00% |
| Q4 2016 | - | 1 | - |
| Q3 2016 | - | 4 | - |
| Q2 2016 | 8 | 5 | 160.00% |
| Q1 2016 | 4 | 4 | 100.00% |
| Q4 2015 | - | 2 | - |
13 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by ARCA biopharma's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 13 | - | - |
| Q1 2024 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 13 | 2 | 650.00% |
| Q4 2021 | 1 | - | - |
| Q2 2021 | 2 | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 1 | - | - |
| Q3 2020 | 3 | - | - |
| Q2 2018 | - | 2 | - |
| Q1 2018 | - | 15 | - |
| Q3 2017 | 1 | - | - |
| Q2 2017 | 1 | 5 | 20.00% |
| Q1 2017 | 1 | 5 | 20.00% |
| Q4 2016 | - | 1 | - |
| Q3 2016 | - | 4 | - |
| Q2 2016 | - | 5 | - |
| Q1 2016 | - | 4 | - |
| Q4 2015 | - | 1 | - |
As of Q3 2024, Insider owners conducted 13 open market buy trades and 0 open market sell trades of ARCA biopharma's stocks.
ARCA biopharma Peer Ownership
| Ticker | Company |
|---|---|
| SIOX | Sio Gene Therapies Inc. |
| MGTA | Dianthus Therapeutics, Inc. |
| NXTC | NextCure, Inc. |
| KTTA | Pasithea Therapeutics Corp. |
| AVTE | Aerovate Therapeutics, Inc. |
| ACRV | Acrivon Therapeutics, Inc. Common Stock |
| CTMX | CytomX Therapeutics, Inc. |
| SPRO | Spero Therapeutics, Inc. |
| QNRX | Quoin Pharmaceuticals, Ltd. |
| ANTX | AN2 Therapeutics, Inc. |
| RNXT | RenovoRx, Inc. |
| RZLT | Rezolute, Inc. |
| INDP | Indaptus Therapeutics, Inc. |
| TPST | Tempest Therapeutics, Inc. |
| ADAG | Adagene Inc. |
| NLTX | Neurogene Inc. |
| TIL | Instil Bio, Inc. |
| FBRX | Forte Biosciences, Inc. |
ABIO Ownership FAQ
Who Owns ARCA biopharma?
ARCA biopharma is owned by institutional shareholders (106.02%), insiders (1.29%), and public (-7.31%). The largest institutional shareholder of ARCA biopharma is PERCEPTIVE ADVISORS LLC (106.94% of total shares) and the top mutual fund owner is TEKLA LIFE SCIENCES INVESTORS (0.07% of total shares).
Who are the major institutional shareholders of ARCA biopharma?
ARCA biopharma's major institutional shareholders are PERCEPTIVE ADVISORS LLC, CABLE CAR CAPITAL LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, RTW INVESTMENTS, LP, and JANUS HENDERSON GROUP PLC. The top five shareholders own together 180.24% of the company's share outstanding.
How many ARCA biopharma shareholders are there?
As of Jun 2024, there are 25 institutional shareholders of ARCA biopharma.
What percentage of ARCA biopharma is owned by PERCEPTIVE ADVISORS LLC?
PERCEPTIVE ADVISORS LLC owns 15.51M shares of ARCA biopharma, representing 106.94% of the company's total shares outstanding, valued at $59.39M (as of Jun 2024).
What percentage of ARCA biopharma is owned by CABLE CAR CAPITAL LLC?
As of Jun 2024, CABLE CAR CAPITAL LLC holds 4M shares of ARCA biopharma (ABIO), compromising 27.59% of the company, valued at $15.32M.
What percentage of ARCA biopharma is owned by DRIEHAUS CAPITAL MANAGEMENT LLC?
DRIEHAUS CAPITAL MANAGEMENT LLC is the third largest holder of ARCA biopharma. The company owns 3.85M of the company's shares outstanding (worth $14.73M).